Notably, the adenosine-generatingenzymes expression levels (CD39, CD73) were found to be decreased, while the activity of adenosine degradation enzyme—ADA—was increased in SLE patients. The gene discussed is ENTPD1; the disease is systemic lupus erythematosus.